Quest Diagnostics Inc $59.48

down -0.50


17/4/2014 06:40 PM  |  NYSE : DGX  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get DGX Trend Analysis - it has underperformed the S&P 500 by 16%

Partner Headlines

  1. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  2. Morning Coffee: Stocks at Historical Low P/B and P/S

    GuruFocus
  3. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  4. US Stock Futures Edge Lower Ahead Of Wholesale Trade Data

    Benzinga
  5. Diamond Hill Capital Comments on Quest Diagnostics

    GuruFocus
  6. Stocks Hitting 52-Week Lows

    Benzinga
  7. UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 ...

    Benzinga
  8. Earnings Scheduled For January 30, 2014

    Benzinga
  9. Quest Buys Solstas Lab for $570M

    FoxBusiness
  10. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  11. Quest Diagnostics Adds Timothy L. Main to Board of Directors

    Benzinga
  12. UC San Francisco, Quest Diagnostics Form Collaboration

    Benzinga
  13. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  14. 5 Leadership Traits That Stock Investors Should Look For

    GuruFocus
  15. Numerous Gurus Hold IDCC, DGX, PTR at 10-Year Low P/B

    GuruFocus
  16. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  17. UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple ...

    Benzinga
  18. Hologic's Opportunity (Icahn Sees It. Do You?)

    GuruFocus
  19. DGX, STO, LSE:DOM - Gurus Hold Stocks Traded at 10-Year Low P/B

    GuruFocus
  20. Quest, LabCorp Plunge: Buying Opportunity?

    YCharts
  21. UPDATE: Morgan Stanley Removes PT on Quest Diagnostics on Model Update ...

    Benzinga
  22. UPDATE: Bank of America Downgrades Quest Diagnostics on Reduced 2014 EPS ...

    Benzinga
  23. Benzinga's Top Downgrades

    Benzinga
  24. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  25. Dividends Are Still The Yield That Matters

    YCharts
  26. Benzinga's Top Initiations

    Benzinga
  27. Danaher Hits New High After Q3 Earnings Beat

    IBD
  28. Earnings Scheduled For October 17, 2013

    Benzinga
  29. J&J Q3 Results: Strong In Pharma, So-So Elsewhere

    IBD
  30. UPDATE: Citigroup Lowers PT on Quest Diagnostics Following Disappointing ...

    Benzinga
  31. Disappointing Preliminary Earnings from Quest Diagnostics Trickles Down ...

    Benzinga
  32. Quest Acquires ConVerge Diagnostic Services

    Benzinga
  33. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD
  34. Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent ...

    Benzinga
  35. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  36. Benzinga Market Primer: Wednesday, January 23

    Benzinga
  37. Earnings Scheduled For January 23, 2013

    Benzinga
  38. Quest selling blood test unit

    IBD
  39. Quest selling blood test unit

    IBD
  40. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  41. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  42. Quest Diagnostics to Sell HemoCue Diagnostic Products Business

    Benzinga
  43. Quest Diagnostics and LabCorp Stocks: Case For a Buying Opportunity

    YCharts
  44. Quest Diagnostics Buys UMass Memorial Medical Center's Outreach Lab Business

    Benzinga
  45. Bio-Reference Earnings Meet Views Despite Hurricane

    IBD
  46. UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Quest ...

    Benzinga
  47. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With ...

    Benzinga
  48. Quest Diagnostics Inc. Reports Operating Results (10-Q)

    GuruFocus
  49. Quest Diagnostics Inc: Fundamental Stock Research Analysis

    GuruFocus
  50. UPDATE: Canaccord Genuity Reduces PT to $59 on Quest Diagnostics

    Benzinga
Trading Center